View Post

Universal Flu Shot Launches Early Clinical Study

In COVID-19, Latest News by Precision Vaccinations

The National Institutes of Health Clinical Center in Bethesda, MD, recently announced a Phase 1 clinical trial of a novel influenza vaccine that has begun inoculating healthy adult volunteers.
This innovative study will evaluate the safety of the whole-virus BPL-1357 vaccine candidate’s ability to prompt immune responses. 
BPL-1357 was developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID).

View Post

Universal Flu Shot Launches Early Clinical Study

In Influenza Vaccine News by Influenza Vaccine

The National Institutes of Health Clinical Center in Bethesda, MD, recently announced a Phase 1 clinical trial of a novel influenza vaccine that has begun inoculating healthy adult volunteers.
This innovative study will evaluate the safety of the whole-virus BPL-1357 vaccine candidate’s ability to prompt immune responses. 
BPL-1357 was developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID).